Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer
N/A
Bladder cancer is a significant global health issue. When the cancer spread...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05
Trial ID
NCT07525349
A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid Tumors
PHASE1
This is an open-lable, single-arm, dose escalation and dose extension phase...
Status
Unknown
Location
Cancer Hospital & Institute, Chinese Academy of Medical Sciences
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
PHASE2
This phase II trial studies how well autologous tumor infiltrating lymphocy...